Overview

Single-Dose Bioequivalence Study Comparing Two 4 mg Nicotine Lozenges

Status:
Completed
Trial end date:
2018-02-17
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the pharmacokinetic (PK) profiles and assess bioequivalence between a new nicotine lozenge and a reference nicotine lozenge in healthy smokers
Phase:
Phase 1
Details
Lead Sponsor:
Fertin Pharma A/S
Treatments:
Nicotine